Miro1 mediates skeletal muscle insulin resistance in type 2 diabetes
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Miro1 mediates skeletal muscle insulin resistance in type 2 diabetes" is generating significant coverage in the Health category, with 7 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Bioengineer.org, Inside Precision Medicine, DongA Science and NewsRadio 1000 KTOK. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 26d ago.
Quick answers
Why is "Miro1 mediates skeletal muscle insulin resistance in type 2 diabetes" trending?
Because 7 independent news sources published 7 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Mitochondrial Protein Miro1 Emerges as a Driver of Muscle Insulin Resistance in Type 2 Diabetes Bioengineer.org · 29d ago
- New Molecular Target for Treating Type 2 Diabetes Identified Inside Precision Medicine · 29d ago
- Oklahoma Diabetes Center Identifies New Protein Target for Type 2 Diabetes Treatment DongA Science · 29d ago
- OKC Scientists Find Protein Linked To Type 2 Diabetes NewsRadio 1000 KTOK · 29d ago
- HOMETOWN HEALTH: Researchers identify new clues for treating type 2 diabetes WDBJ7 · 29d ago
- Muscle protein Miro1 may drive insulin resistance, revealing potential type 2 diabetes treatment target Medical Xpress · 29d ago
- Miro1 mediates skeletal muscle insulin resistance in type 2 diabetes Nature · 29d ago
Topics
Related trends
Key immune driver of pancreatic cancer points to combination treatment for slowing progression
The aging human brain exhibits reduced hemodynamic and cerebrospinal fluid flow waves during sleep
Possible measles exposure at Hickory church, pediatric office
Cancer society issues most specific prostate cancer screening guidelines yet
26 More Measles Cases in New York, but Outbreak Appears to Be Easing
GLP-1 poison calls surge in Georgia as experts warn about unapproved weight-loss drugs - WSB-TV
Georgia poison centers report a surge in calls linked to GLP-1 weight-loss drugs as experts flag risks from unapproved versions.